Trials / Completed
CompletedNCT03183505
Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb
Safety and Efficacy Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Ⅱb Stratified Randomized, Double-Blind, Placebo-Paralleled, Multicenter Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 172 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Anyu Peibo Capsule comparing with placebo in the treatment of Chinese Patients with Depression. And to provide some scientific evidence for protocol designing in following phase Ⅲ clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anyu Peibo | Anyu Peibo Capsule, 0.8g twice per day, oral after breakfast and supper |
| DRUG | Placebo | Placebo Capsule, twice per day, oral after breakfast and supper |
Timeline
- Start date
- 2017-06-30
- Primary completion
- 2018-10-05
- Completion
- 2018-11-29
- First posted
- 2017-06-12
- Last updated
- 2019-01-23
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03183505. Inclusion in this directory is not an endorsement.